Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...

A new trial found that a progesterone-mimicking drug used to manage hot flashes and other symptoms may have anticancer properties when combined with anti-estrogen drugs for breast cancer.

One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.

Central review changed the assessment of receptor status in a substantial proportion of patients, and should be performed whenever possible in similar trials. PgR expression did not affect the ...

A research team led by Hiroshima University and Tokyo University of Agriculture and Technology have proposed a neuroendocrine mechanism in bony fish that signals ovulation from the ovaries to the ...